Revenue stood at KD 99 million, representing a growth of 6.5% compared to 2023 full-year revenue. The Non-Food Business Line accounted for 34.6% of Group Revenue. The Business Line comprises the ...

Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Ascendis Pharma (ASND – Research Report) today and set a price target of $180.00. The company’s shares closed last Friday at ...

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.

A U.K. government proposal to raise mandatory rebates that drug companies are required to pay to bolster the National Health Service has sparked criticism from an industry trade group, which ...

The Noramco Group’s investment will provide branded and generic pharmaceutical companies with a North American-based solution for sterile injectable manufacturing, strengthening the domestic ...

LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an investment of over $6 million to expand its Rosenberg, Texas manufacturing ...

Learn More About Halo Pharma’s New Sterile Manufacturing Capabilities at DCAT Week 2025— The Noramco Group, an integrated North American-based API and drug product supply chain product and ...

(MENAFN- GlobeNewsWire - Nasdaq) In the USA Omega-3 market is shifting toward pharma-grade formulations, driven by rising cardiovascular prescriptions. Leading players like KD Pharma, DSM ...

An ad for compounded versions of weight-loss drug semaglutide by telehealth company Hims & Hers has attracted the ire of a pharmaceutical trade organisation that calls the campaign "nothing short ...

The rising prevalence of lifestyle diseases, coupled with the global shift toward preventive healthcare, is propelling the demand for high-purity, pharmaceutical-grade Omega-3 products.

NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Kyndryl Holdings, Inc. (NYSE: KD), the world's largest IT infrastructure services provider, today announced that Chairman and Chief Executive Officer Martin ...

The Swiss pharma group is in the throes of a major restructuring exercise since it spun off its Sandoz generics unit last November, which has included job cuts and a narrowing of its R&D focus to ...